US2016159916A1PendingUtilityA1
Method of treating diabetes, and diseases associated with impaired glucose tolerance
Est. expiryJun 6, 2026(expired)· nominal 20-yr term from priority
A61P 3/08A61P 3/10A61P 5/50A61P 3/04A61K 41/0004A61K 2039/505C07K 16/2869A61K 39/395
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application provides a method of treating diabetes mellitus, impaired glucose tolerance and obesity associated with diabetes mellitus or impaired glucose tolerance, the method comprising administering to a subject in need thereof a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor.
Claims
exact text as granted — not AI-modified1 .- 5 . (canceled)
6 . A method of treating diabetes mellitus, the method comprising administering to a subject in need thereof a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor.
7 . The method according to claim 6 wherein said at least one antibody is a monoclonal, polyclonal, recombinant, immune or natural antibody.
8 . The method according to claim 6 wherein said homeopathically potentised form of antibody comprises mixture of various homeopathic dilutions.
9 . A method of treating impaired glucose tolerance the method comprising administering to a subject in need thereof a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor.
10 . The method according to claim 9 wherein said at least one antibody is a monoclonal, polyclonal, recombinant, immune or natural antibody.
11 . The method according to claim 9 wherein said homeopathically potentised form of antibody comprises mixture of various homeopathic dilutions.
12 . A method of treating obesity associated with diabetes mellitus or impaired glucose tolerance, the method comprising administering to a subject in need thereof a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor
13 . The method according to claim 12 wherein said at least one antibody is a monoclonal, polyclonal, recombinant, immune or natural antibody.
14 . The method according to claim 12 wherein said homeopathically potentised form of antibody comprises mixture of various homeopathic dilutions.Join the waitlist — get patent alerts
Track US2016159916A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.